ES497361A0 - Un metodo de liofilizacion de una composicion viral acuosa - Google Patents

Un metodo de liofilizacion de una composicion viral acuosa

Info

Publication number
ES497361A0
ES497361A0 ES497361A ES497361A ES497361A0 ES 497361 A0 ES497361 A0 ES 497361A0 ES 497361 A ES497361 A ES 497361A ES 497361 A ES497361 A ES 497361A ES 497361 A0 ES497361 A0 ES 497361A0
Authority
ES
Spain
Prior art keywords
viral composition
lyophilization method
lyophilization
aqueous
aqueous viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES497361A
Other languages
English (en)
Other versions
ES8205306A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8205306A1 publication Critical patent/ES8205306A1/es
Publication of ES497361A0 publication Critical patent/ES497361A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES497361A 1979-12-03 1980-12-02 Un metodo de liofilizacion de una composicion viral acuosa Granted ES497361A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/099,772 US4273762A (en) 1979-12-03 1979-12-03 Lyophilization process for live viral compositions

Publications (2)

Publication Number Publication Date
ES8205306A1 ES8205306A1 (es) 1982-06-01
ES497361A0 true ES497361A0 (es) 1982-06-01

Family

ID=22276548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497361A Granted ES497361A0 (es) 1979-12-03 1980-12-02 Un metodo de liofilizacion de una composicion viral acuosa

Country Status (10)

Country Link
US (1) US4273762A (es)
EP (1) EP0030199B1 (es)
JP (1) JPS5692822A (es)
AT (1) ATE6201T1 (es)
CA (1) CA1146861A (es)
DE (1) DE3066651D1 (es)
DK (1) DK512780A (es)
ES (1) ES497361A0 (es)
GR (1) GR71638B (es)
PT (1) PT72105B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
GB8802174D0 (en) * 1988-02-01 1988-03-02 Quadrant Bioresources Ltd Method of drying macromolecules
US5169834A (en) * 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
CZ289574B6 (cs) * 1992-06-04 2002-02-13 Merck And Co., Inc. Způsob výroby ľivé, atenuované vakcíny viru varicella zoster
PT651789E (pt) * 1992-07-17 2002-05-31 Merck & Co Inc Metodo para a prevencao de zoster ou alivio de neuralgia pos-herpetica relacionada com varicela
CA2158935A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
CA2177060A1 (en) * 1993-12-21 1995-06-29 Philip J. Provost Thermostable varicella zoster virus
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
AU725231B2 (en) * 1996-12-20 2000-10-12 Merck & Co., Inc. Stabilisers for lyophilised vaccines
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
RU2144369C1 (ru) * 1998-12-28 2000-01-20 Трифонов Валерий Дмитриевич Живая культуральная коревая вакцина
US6465207B1 (en) 2000-11-03 2002-10-15 Cytologix Corporation Silver-based staining processes employing non-gelling gelatin
ES2536322T3 (es) * 2003-12-17 2015-05-22 Wyeth Llc Procedimiento para producir composiciones de VSR estables en almacenamiento
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197374A (en) * 1962-10-11 1965-07-27 Behringwerke Ag Process for the disaggregation and purification of viruses
BE622212A (es) *
NL285236A (es) *
US3183161A (en) * 1955-05-02 1965-05-11 Parke Davis & Co Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
US3078215A (en) * 1959-12-22 1963-02-19 Glaxo Group Ltd Process for the purification and concentration of poliomyelitis vaccine
GB960642A (en) * 1961-04-06 1964-06-10 Pfizer & Co C Measles vaccine
US3133861A (en) * 1961-11-08 1964-05-19 Dow Chemical Co Attenuated live measles virus vaccine and method of production
US3132073A (en) * 1962-03-14 1964-05-05 Lilly Co Eli Measles vaccine
US3478145A (en) * 1964-09-15 1969-11-11 American Home Prod Chromatographic purification of virus with brushite modified by autoclaving
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3629399A (en) * 1967-09-05 1971-12-21 Behringwerke Ag Stable poliomyelitis vaccines
FR1604134A (es) * 1967-09-26 1971-07-12
US3509070A (en) * 1968-06-13 1970-04-28 American Home Prod Adsorbent for chromatographic purification of virus
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3933585A (en) * 1972-06-14 1976-01-20 Merck & Co., Inc. Process for production of vaccines
IL44143A0 (en) * 1973-02-07 1974-05-16 Wellcome Found Method of inactivating viruses and vaccines prepared thereby
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3961046A (en) * 1974-12-02 1976-06-01 American Cyanamid Company Mumps vaccine and preparation thereof
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer

Also Published As

Publication number Publication date
JPS5692822A (en) 1981-07-27
EP0030199A3 (en) 1982-06-09
DE3066651D1 (en) 1984-03-22
CA1146861A (en) 1983-05-24
DK512780A (da) 1981-06-04
ES8205306A1 (es) 1982-06-01
EP0030199A2 (en) 1981-06-10
US4273762A (en) 1981-06-16
ATE6201T1 (de) 1984-03-15
PT72105A (en) 1980-12-01
PT72105B (en) 1982-06-25
GR71638B (es) 1980-11-29
EP0030199B1 (en) 1984-02-15

Similar Documents

Publication Publication Date Title
GR71638B (es)
JPS51121239A (en) An amplification circuit
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
MX6534E (es) Composicion mejorada de una microemulsion acuosa
AU507778B2 (en) Generating pulsed output representative of roadspeed
FR2448254A1 (fr) Amplificateur d'impulsions a haute frequence
MX163530B (es) Composicion de activador adaptada para producir una luz quicoluminiscente y metodo para su preparacion
NL174371C (nl) Rabiesvirus; uit dit virus bereid vaccin alsmede lokaas waarin dit vaccin is opgenomen.
BG31070A3 (bg) Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини
JPS5222853A (en) Amplifier
JPS51120696A (en) Laser oscillator
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG35749A3 (bg) Метод за получаване на 20-дихидро-20,23-дидеокситидонолид
IT1051058B (it) Unita di comando per generare segnali di uscita di elevata intensita di corrente
BG33159A3 (bg) Метод за получаване на производни на еритромицин а
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
BG28577A3 (bg) Метод за получаване на триазолотиенодиазепин-1-они
JPS51117890A (en) Mode synchronous laser device
JPS5223321A (en) Drum
ES205975Y (es) Una disposicion de union de vigas de madera.
JPS51140461A (en) Linear output amplifier with no distortion at low level of signal
JPS547812A (en) Signal amplifyng unit
BG34035A3 (en) A method of obtaining 2- hydroxyamino- 1, 2, 3, 4, 6, 7- hexahydro- 11bh- benzo (a) quinolysine derivatives
JPS5274203A (en) Hearing aid
JPS51128291A (en) Rectangular laser unit